Adalimumab therapy for refractory uveitis: a pilot study.
Diaz-Llopis M, García-Delpech S, Salom D, Udaondo P, Hernández-Garfella M, Bosch-Morell F, Quijada A, Romero FJ.
Diaz-Llopis M, et al.
J Ocul Pharmacol Ther. 2008 Jun;24(3):351-61. doi: 10.1089/jop.2007.0104.
J Ocul Pharmacol Ther. 2008.
PMID: 18476805
Clinical Trial.